According to Sundar Pichai, the C2S-Scale 27B foundation model, developed in partnership with Yale and based on Gemma architecture, has generated a novel hypothesis about cancer cellular behavior. This hypothesis was experimentally validated in living cells by scientists, marking a significant achievement for AI-driven biomedical research. With further preclinical and clinical testing, this AI-powered discovery could unlock new pathways for developing cancer therapies, demonstrating the transformative impact of large language models in accelerating scientific breakthroughs and pharmaceutical innovation (source: @sundarpichai on Twitter, Oct 15, 2025).